IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus
Open Access
- 1 January 2013
- journal article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 12 (1), 26
- https://doi.org/10.1186/1476-4598-12-26
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Radiotherapy versus surgery within multimodality protocols for esophageal cancer – A meta-analysis of the randomized trialsCancer Treatment Reviews, 2012
- Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisThe Lancet Oncology, 2011
- Significance of Interleukin-6 Signaling in the Resistance of Pharyngeal Cancer to Irradiation and the Epidermal Growth Factor Receptor InhibitorInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cellsEndocrine-Related Cancer, 2010
- Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal CancerJournal of Clinical Oncology, 2009
- IL-6 involvement in epithelial cancersJCI Insight, 2007
- The Prognostic Significance of Plasma Interleukin-6 Levels in Patients with Metastatic Hormone-Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 9480Clinical Cancer Research, 2005
- Cytokines in cancer immunity and immunotherapyImmunological Reviews, 2004
- Inflammation and cancerNature, 2002
- Interleukin-6 in Biology and MedicineAdvances in Immunology, 1993